-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Actinium Pharmaceuticals, Inc. annual/quarterly Revenues history and growth rate from 2021 to 2023.
- Actinium Pharmaceuticals, Inc. Revenues for the quarter ending December 31, 2022 was $0.000, a 100% decline year-over-year.
- Actinium Pharmaceuticals, Inc. Revenues for the twelve months ending December 31, 2022 was $1.03M, a 9.97% decline year-over-year.
- Actinium Pharmaceuticals, Inc. annual Revenues for 2023 was $81K, a 92.1% decline from 2022.
- Actinium Pharmaceuticals, Inc. annual Revenues for 2022 was $1.03M, a 9.97% decline from 2021.